GO
Loading...

Covidien PLC

More

  • Midday Glance: Health Care Equipment companies Wednesday, 30 Jul 2014 | 1:22 PM ET

    Becton, Dickinson& Co. fell$. 05 or percent, to $118.81. Patterson fell$. 11 or. 3 percent, to $39.24. PerkinElmer fell$. 11 or. 2 percent, to $47.04.

  • Early Glance: Health Care Equipment companies Wednesday, 30 Jul 2014 | 10:42 AM ET

    Becton, Dickinson& Co. rose$. 03 or percent, to $118.89. Covidien plc rose$. 08 or. 1 percent, to $87.22. PerkinElmer rose$. 08 or. 2 percent, to $47.23.

  • DUBLIN, July 30- Ireland is in the firing line from Washington again for luring U.S. companies to its shores for tax benefits, but despite contrite noises coming from Dublin, it has too much to lose to discourage U.S. firms bent on shifting their tax domiciles.

  • Final Glance: Health Care Equipment companies Monday, 28 Jul 2014 | 6:04 PM ET

    Becton, Dickinson& Co. rose$. 45 or. 4 percent, to $118.82. Covidien fell$. 69 or. 8 percent, to $87.10. Thermo Fisher Scientific Inc. fell$. 69 or. 6 percent, to $124.38.

  • Midday Glance: Health Care Equipment companies Monday, 28 Jul 2014 | 1:31 PM ET

    Becton, Dickinson& Co. fell$. 23 or. 2 percent, to $118.14. Covidien plc fell$. 45 or. 5 percent, to $87.34. PerkinElmer fell$. 45 or. 9 percent, to $47.37.

  • Early Glance: Health Care Equipment companies Monday, 28 Jul 2014 | 10:33 AM ET

    Becton, Dickinson& Co. fell$. 34 or. 3 percent, to $118.03. Covidien plc fell$. 51 or. 6 percent, to $87.28. PerkinElmer fell$. 33 or. 7 percent, to $47.49.

  • DUBLIN, July 25- Ireland defended its tax regime on Friday against criticism from U.S. Singling out Ireland for criticism, Obama on Thursday hammered U.S. companies that avoid federal taxes by shifting their tax domiciles overseas and called on Congress to pass a bill to curb such deals, known as "inversions".

  • Final Glance: Health Care Equipment companies Thursday, 24 Jul 2014 | 6:22 PM ET

    Becton, Dickinson& Co. fell$. 12 or. 1 percent, to $118.49. Covidien fell$. 19 or. 2 percent, to $89.10. PerkinElmer rose$. 07 or. 1 percent, to $47.72.

  • Midday Glance: Health Care Equipment companies Thursday, 24 Jul 2014 | 1:23 PM ET

    Becton, Dickinson& Co. fell$. 14 or. 1 percent, to $118.47. Covidien plc fell$. 55 or. 6 percent, to $88.74. PerkinElmer rose$. 16 or. 3 percent, to $47.81.

  • Early Glance: Health Care Equipment companies Thursday, 24 Jul 2014 | 11:37 AM ET

    Becton, Dickinson& Co. fell$. 06 or. 1 percent, to $118.55. Covidien plc rose$. 11 or. 1 percent, to $89.40. PerkinElmer fell$. 01 or percent, to $47.64.

  • Final Glance: Health Care Equipment companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Becton, Dickinson& Co. rose$. 40 or. 3 percent, to $118.24. Covidien rose$. 36 or. 4 percent, to $88.89. PerkinElmer rose$. 57 or 1.2 percent, to $47.65.

  • Midday Glance: Health Care Equipment companies Tuesday, 22 Jul 2014 | 1:57 PM ET

    Becton, Dickinson& Co. rose$. 96 or. 8 percent, to $118.80. Covidien plc rose$. 67 or. 8 percent, to $89.20. PerkinElmer rose$. 69 or 1.5 percent, to $47.77.

  • Glance: Biggest corporate deals so far this year Friday, 18 Jul 2014 | 11:57 AM ET

    Abbvie Inc.' s deal to combine with Shire PLC would be the largest made so far this year, excluding assumed debt.

  • Early Glance: Health Care Equipment companies Friday, 18 Jul 2014 | 11:13 AM ET

    Becton, Dickinson& Co. fell$. 03 or percent, to $117.57. Covidien plc rose $1.00 or 1.1 percent, to $88.05. Patterson fell$. 03 or. 1 percent, to $38.65.

  • AbbVie, Shire agree on $55B combination Friday, 18 Jul 2014 | 6:43 AM ET

    The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home. But the new company will be controlled by shareholders of North Chicago, Illinois- based AbbVie, who will own about 75 percent of the new company's stock.

  • July 17- U.S. orthopedics company Stryker Corp on Thursday reported slightly higher second-quarter profit that was in line with Wall Street expectations and said it was always in the market for deals. In the most recent such deal in the medical device sector, Medtronic Inc last month agreed to buy Covidien for $43 billion.

  • UPDATE 2-St. Jude not keen to join inversion deal craze Wednesday, 16 Jul 2014 | 3:39 PM ET

    In the most recent such deal in the medical device sector, Medtronic Inc last month agreed to buy Covidien for $43 billion. The move will allow Medtronic to re-domicile to Ireland to take advantage of low corporate tax rates and to access cash overseas without having to pay high repatriation costs.

  • Treasury Secretary Jacob Lew urged Congress on Wednesday to take steps quickly to discourage U.S. companies from moving their tax domiciles abroad to avoid federal taxes. "Congress should enact legislation immediately," Lew told a business conference in New York hosted by cable television channel CNBC.

  • FACTBOX-M&A frenzy transforming global pharma Monday, 14 Jul 2014 | 9:27 AM ET

    July 14- Several multi-billion dollar deals and bids have made 2014 a busy year for healthcare acquisitions, despite Pfizer pulling its $118 billion offer for AstraZeneca.

  • July 11- Medical device maker Covidien Plc said it recorded a pre-tax charge of about $180 million for the third quarter, related to litigation against some manufacturers of pelvic mesh products. Covidien said it was indemnifying the manufacturer on certain claims.